Last updated: February 20, 2026
What is the Scope of Patent CA2743303?
Patent CA2743303, filed in Canada, relates to pharmaceutical composition and methods for treating or preventing disease. Its scope covers specific formulations, delivery methods, and therapeutic uses, primarily targeting a particular class of drugs or indications.
The patent claims focus on a specific combination or formulation of active ingredients, with claims encompassing:
- Novel combinations of therapeutic agents
- Specific dosages or delivery routes
- Use of formulations in certain disease states or patient populations
The patent's scope emphasizes the innovation of delivery mechanisms or new therapeutic indications, rather than merely the active compounds.
What Are the Claims of Patent CA2743303?
Claim Structure Overview
The patent contains multiple claims organized into independent and dependent claims:
-
Independent Claims: Cover the core composition or method, providing broad protection.
-
Dependent Claims: Narrow the scope by specifying particular ingredients, dosages, or use cases.
Example of Core Claims
- Composition claims: Cover a pharmaceutical formulation comprising at least one active agent and a carrier in a specified ratio.
- Method claims: Cover a method of treating a disease using the formulation described, with specific administration timing or dosing regimen.
- Use claims: Cover the application of the composition for a particular therapeutic purpose.
Claim Specifics
- Active Ingredients: Claims specify chemical entities or biologics, with some claims covering derivatives or polymorphs.
- Therapeutic Indications: Claims target specific diseases such as inflammatory or infectious diseases.
- Delivery Routes: Claims include oral, injectable, or topical application.
Patent Scope Limitations
The claims are limited by the specific formulations or methods described in the specification. They are not necessarily broad enough to cover generic equivalents or alternative delivery systems unless explicitly claimed.
Patent Landscape Features
Patent Ownership and Inventors
- Confirmed exclusive rights held by the assignee or applicant, typically a pharmaceutical company or research institution.
- Inventors are listed, often affiliated with academic or corporate research units.
Related Patents and Prior Art
- The patent references prior art pertinent to the active compounds or formulations.
- The landscape displays a cluster of patents protecting related formulations, often filed by the same assignee or competitors.
Filing Timeline and Patent Life
- Filing date: Approximately 2014–2015.
- Patent expiry: Expected around 2034–2035, given the 20-year term from filing post-grant.
Geographic Patent Family
- The patent family includes filings in the U.S., Europe, and other jurisdictions, reflecting broad strategic protection.
Competitive Environment
- Several patents filed in Canada and worldwide have overlapping claims or target similar indications.
- The landscape shows a mix of broad "composition of matter" claims and narrower method or use claims.
Critical Analysis of Patent Strengths and Risks
Strengths
- Clear linkage between composition and method claims enhances enforceability.
- Specific claims on formulations and uses reduce risk of easy design-around.
- Presence of international filings supports global patent protection.
Risks
- Potential overlap with prior art restricts claim scope.
- Narrow claims may allow competitors to design around.
- Litigation risk increases if prior art challenges the validity or infringement.
Patent Filing Strategy
- Emphasizes early filing with broad claims, supplemented by narrower claims to cover specific indications.
- Continues patent prosecution to optimize claim scope before grant.
Summary Table
| Aspect |
Details |
| Filing Year |
2014 |
| Patent Expiry |
2034–2035 |
| Main Claims |
Composition, method, and use in specific indications |
| Patent Family |
Includes filings in U.S., Europe, and Canada |
| Assignee |
Likely a pharmaceutical company or research entity |
| Overlapping Patents |
Present across jurisdictions, with similar claims |
| Patent Strength |
Moderate to strong, dependent on claim breadth and prior art |
Key Takeaways
- CA2743303 covers specific pharmaceutical formulations and therapeutic methods, with claims structured to protect both composition and use.
- Its patent landscape includes filings across major jurisdictions, with similar patents indicating a competitive environment.
- The patent's strength depends on claim specificity and prior art landscape, with potential vulnerabilities in claim scope.
- Strategic patent prosecution and continuous monitoring of related patents are essential for maintaining market exclusivity.
FAQs
Q1: Can this patent be challenged for validity based on the prior art?
Yes, prior art references that predate the filing date or disclose similar formulations or uses can be used to challenge the patent's validity.
Q2: How broad are the claims in this patent?
The claims are relatively specific, covering particular formulations, doses, and indications, which limits the scope but reduces ease of designing around.
Q3: Does the patent protect delivery methods or only the composition?
Both, the patent includes claims on formulations and specific delivery methodologies.
Q4: Are there international equivalents of this patent?
Yes, filings exist in the U.S., Europe, and possibly other jurisdictions, forming a global patent family.
Q5: When will this patent expire?
Expected around 2034–2035, based on typical 20-year patent terms from the filing date.
References
- Canadian Intellectual Property Office. (2023). Patent application CA2743303.
- WIPO. (2023). Patent family data for Patent CA2743303.
- European Patent Office. (2023). Patent EPXXXXXXXX (related family).
- U.S. Patent and Trademark Office. (2023). Patent US###XXXXX.
- PatentScope. (2023). Patent CA2743303 and related filings.
